Opko Health, Inc. (OPK) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Opko Health reported revenue of $606.9M, down 14.9% from $713.1M the year before. Net income was -$225.7M (a -37.2% net margin), or -$0.30 per diluted share. Gross margin was 33.9% and operating margin was -19.3%. Operating activities generated -$178.5M of cash, leaving -$190.8M of free cash flow. At fiscal year end, Opko Health held $1.93B in total assets against $664.0M in total liabilities, including $364.4M of cash and equivalents.
Open the full interactive Opko Health financials → Quarterly statements, key ratios, valuation history and price charts.
Opko Health Key Stats
| Share Price | $1.32 |
|---|---|
| Market Cap | $997.0M |
| Revenue YoY Growth | -14.9% |
| 52-Week Range | $1.10 – $1.73 |
| Shares Outstanding | 755.3 million (basic, 2026 Q2) |
Opko Health Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.44B | $1.77B | $1.00B | $863.5M | $713.1M | $606.9M |
| Cost of Goods Sold | $70.5M | $91.0M | $88.4M | $99.5M | $494.6M | $400.9M |
| Gross Profit | $1.36B | $1.68B | $915.8M | $764.0M | $218.5M | $205.9M |
| Operating Income | $57.7M | $18.8M | -$226.3M | -$157.0M | -$152.1M | -$117.4M |
| Pre-Tax Income | $48.7M | -$14.0M | -$391.5M | -$184.3M | -$10.4M | -$241.4M |
| Income Tax | $17.6M | $15.5M | -$63.5M | $4.4M | $42.8M | -$15.7M |
| Net Income | $30.6M | -$30.1M | -$328.4M | -$188.9M | -$53.2M | -$225.7M |
| Diluted EPS | $0.05 | -$0.05 | -$0.46 | — | $0.01 | -$0.30 |
Opko Health Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $151.7M | $148.5M | $124.2M | $163.6M |
| Net Income | $21.6M | -$31.3M | -$54.8M | -$8.4M |
| Diluted EPS | $0.03 | -$0.04 | -$0.07 | -$0.01 |
Opko Health Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $72.2M | $134.7M | $153.2M | $95.9M | $426.6M | $364.4M |
| Current Assets | $523.2M | $823.0M | $394.5M | $309.5M | $662.1M | $581.9M |
| Total Assets | $2.47B | $2.40B | $2.17B | $2.01B | $2.20B | $1.93B |
| Current Liabilities | $375.5M | $330.0M | $213.5M | $200.1M | $193.1M | $146.7M |
| Total Long-Term Debt | $251.2M | $205.3M | $256.3M | $9.7M | $4.4M | $346.2M |
| Total Liabilities | $801.5M | $714.6M | $605.6M | $622.5M | $834.8M | $664.0M |
| Shareholders' Equity | $1.67B | $1.69B | $1.56B | $1.39B | $1.37B | $1.27B |
Opko Health Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $39.5M | $38.3M | -$95.2M | -$28.2M | -$183.5M | -$178.5M |
| Cash From Investing | -$18.3M | $35.9M | $91.0M | -$18.2M | $352.2M | $230.3M |
| Cash From Financing | -$35.1M | -$10.4M | $23.0M | -$11.3M | $184.2M | -$118.1M |
| Free Cash Flow | $5.8M | $6.2M | -$119.8M | -$44.5M | -$208.5M | -$190.8M |
Figures from Opko Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Opko Health financials page for every line item.
Opko Health Company Profile
| Ticker | OPK |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Miami, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0000944809 |
Frequently Asked Questions
What was Opko Health's revenue in fiscal 2025?
Opko Health (OPK) reported revenue of $606.9M for fiscal 2025.
What is Opko Health's annual revenue history?
Opko Health's annual revenue by fiscal year: 2020: $1.44B; 2021: $1.77B; 2022: $1.00B; 2023: $863.5M; 2024: $713.1M; 2025: $606.9M.
What was Opko Health's net income in fiscal 2025?
Opko Health reported net income of -$225.7M for fiscal 2025.
What was Opko Health's earnings per share (EPS) in fiscal 2025?
Opko Health's diluted EPS was -$0.30 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Opko Health generate in fiscal 2025?
Opko Health generated -$190.8M of free cash flow in fiscal 2025.
What was Opko Health's revenue last quarter?
In its most recent reported quarter (2026 Q2), Opko Health reported revenue of $163.6M.
How much debt does Opko Health have?
Opko Health reported $346.2M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Opko Health are outstanding?
Opko Health reported a weighted average of 755.3 million basic shares outstanding in 2026 Q2.
What is Opko Health's market cap?
Based on its latest closing price, Opko Health (OPK) has a market capitalization of about $997.0M.
When does Opko Health's fiscal year end?
Opko Health's fiscal year end, as registered with the SEC, is December 31.
Where is Opko Health headquartered?
Opko Health lists its business address in Miami, Florida in its SEC filings.